Hernia
Protrusion of tissue, structure, or part of an organ through the bone, muscular tissue, or the membrane by which it is normally contained. Hernia may involve tissues such as the ABDOMINAL WALL or the respiratory DIAPHRAGM. Hernias may be internal, external, congenital, or acquired.
Subtype terms (8)
More specific conditions that are subtypes of Hernia in the MeSH hierarchy.
- Encephalocele
2 drugs approved
- Hernia, Abdominal
15 drugs (14 approved, 1 experimental)
- Hernia, Obturator
- Incisional Hernia
7 drugs (5 approved, 2 experimental)
- Internal Hernia
- Intervertebral Disc Displacement
27 drugs (16 approved, 11 experimental)
- Meningocele
- Rectocele
1 drug approved
Drugs by status
Approved for this indication (1)
Phase 4 trials (13)
Phase 3 trials (10)
Phase 2 trials (1)
Phase 1 trials (2)
Organizations
Organization Involved with Phase 4 Indications (35)
- Baxalta
- Teva
- United States Navy
- Hospital Italiano de Buenos Aires
- Mahidol University
- Maimonides Medical Center
- Memorial Health University Medical Center
- Northwestern University
- Tufts University
- University of Florida
- University of Kansas
- University of Medicine and Dentistry of New Jersey
- University of Pavia
- University of Southern California
- University of California, San Francisco
- University of Cincinnati
- University of Copenhagen
- Consorci Hospitalari de Vic
- Pacira Pharmaceuticals
- University of Ankara
- University of Missouri
- Isfahan University
- Hebrew University
- Louisiana State University
- Vic Hospital Consortium
- Technion University
- Universidad de Alcala, Madrid
- Kantonsspital Baden
- Ostfold University
- Yeshiva University
- +5 more
Organization Involved with Phase 3 Indications (29)
- Bausch Health Companies
- Pfizer
- Progenics
- Innocoll
- Seikagaku Corporation
- University of Pennsylvania
- Duke University
- Greenville Health System
- Kyung Hee University
- KK Women's and Children's Hospital
- Mayo General Hospital, Ireland
- Ohio State University
- Oregon Health and Science University
- Rijnstate Hospital
- University of The West Indies
- University Hospital Koge
- University of Malaya
- Mayo Clinic
- Pennsylvania State University
- University of Massachusetts
- Washington University in St. Louis
- Erasmus University Rotterdam
- Singapore Institute for Clinical Sciences
- New Hanover Regional Medical Center
- CMed Technologies Inc.
- Dongguk University
- Government of Singapore
- Daegu Haany University
- Prisma Health
Organization Involved with Phase 2 Indications (17)
- AlgoRx Pharmaceuticals
- Nycomed
- Sintetica SA
- Taiwan Liposome Company
- Durect
- National Institutes of Health (NIH)
- National Institute on Drug Abuse (NIDA)
- Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
- University of Kentucky
- University of Ottawa
- University of Thessaly
- Zagazig University
- Premier Research Group
- State University of New York, Buffalo
- George Washington University
- SRL Medisearch
- National Institute of Child Health and Human Development (NICHD)
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (38)
- McNeil
- Merck
- United States Army
- Ataturk University
- Case Western Reserve University
- Johns Hopkins University
- Kocaeli University
- Luzerner Kantonsspital
- Makassed General Hospital
- Maltepe University
- Mansoura University
- Medical College of Wisconsin
- Marmara University
- University of Rochester
- University of Toronto
- University of Bern
- Yonsei University
- Aga Khan University
- Dalhousie University
- University of Calgary
- University of Basel
- University of Auckland
- Bar Ilan University
- Istanbul Medipol University
- Jiao Tong University
- Yeditepe University
- GZO Spital Wetzikon
- Cantonal Hospital of St. Gallen
- Children's Anesthesiology Associates, Ltd.
- John P. Murtha Neuroscience and Pain Institute
- +8 more